Hypotension, acidosis, and vasodilatation syndrome post-heart transplant: Prognostic variables and outcomes

Journal of Heart and Lung Transplantation

Volumn 20, Issue 10, 2001, Pages 1075-1083

  Chemmalakuzhy, J ^a,b   Costanzo, M R ^a   Meyer, P ^a   Piccione, W ^a   Kao, W ^a   Winkel, E ^a   Saltzberg, M ^a   Heroux, A ^a   Parrillo, J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BICARBONATE;

ACIDOSIS; ADULT; ANALYTIC METHOD; ARTICLE; BICARBONATE BLOOD LEVEL; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEGRO; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RISK FACTOR; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; VASODILATATION; WEIGHT;

ACIDOSIS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNDROME; VASODILATION;

EID: 0034810690     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00299-6     Document Type: Article

References (31)

1. Twenty-fourth Bethesda conference: Cardiac transplantation: Task Force 3: Recipient guidelines/prioritization
2. Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up: A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology
3. Cerebral injury and cardiac operations
4. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
5. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement
6. Mechanisms of lung injury
7. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
8. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass
9. Reversal of intractable septic shock with norepinephrine therapy
10. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass
11. Vasodilatory hypotension after cardiopulmonary bypass: Risk factors and potential mechanisms
12. Ace-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass: A case-control study
13. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: A multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD)
14. Preoperative obesity is associated with decreased survival after heart transplantation
15. Cardiac transplantation
16. Cardiac allograft vasculopathy: Current concepts recent developments, and future directions
17. The spectrum of coronary artery pathological findings in human cardiac allografts
18. Prevalence of accelerated coronary artery disease in heart transplant survivors: Comparison of cyclosporine and azathioprine regimes
19. Hemodynamics and physiologic changes during support with an implantable left ventricular assist device
20. Evolving experience with mechanical circulatory support
21. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system
22. Bridge experience with long-term implantable left ventricular assist device
23. Results of extended bridge to transplantation window into the future of permanent ventricular assist device
24. One-hundred HeartMate LVAD patients: Evolving concepts and technology
25. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy
26. Improved left ventricular function after chronic left ventricular unloading
27. Case report: Circulatory support for 70 days with resolution of acute heart failure
28. Weaning from mechanical support in patients with dilated cardiomyopathy
29. A novel approach to the treatment of vasodilatory shock after heart transplantation
30. Systemic inflammatory response syndrome after cardiac operations